Related Experiment Video
Updated: Jul 15, 2026

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
New trends in the treatment of scleroderma renal crisis
1Department of Internal Medicine E, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract:
The main pathological changes observed in scleroderma kidney are edema and proliferation of intimal cells, glomerular changes with thickening and obliteration of arteries leading to decreased renal perfusion and increased renin release. Angiotensin converting enzyme inhibitors are the cornerstone in the treatment of patients with scleroderma renal crisis. Statins are used in the prevention of primary and secondary cardiovascular events. These drugs control cell proliferation and may prevent the injury observed in scleroderma kidney.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Nephrotic Syndrome III : Nursing Management
Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care

